These outcomes imply that CDKN2A might exert its influence on the immune microenvironment in colorectal cancer by means of immune cells or tumor-infiltrating lymphocytes (TILs), aligning with prior investigations [28, 29]. This evidence concerns the gene CDKN2A and colorectal cancer.